BioWorld Asia

April 9, 2003

Serono Signs On Graffinity As Partner For Drug Development

Graffinity AG, a specialist in preclinical drug discovery, landed a commitment from Serono SA to help fill the development pipeline of Europe's largest biotechnology company. (BioWorld International) Read More

Epigenomics Raises EUR21M To Fund Work In DNA Methylation

Angiogenesis Study Encourages Prospects In Ischemia Treatment

GeneProt Slashes Staff, Cites Current Economic Environment

Ester Neuroscience Gets Good Results In Early Antisense Trial

Chiasma Gets First Biotech Investment From InnoMed

Galapagos Enters Collaboration In Nutraceuticals With Degussa

European Officials Craft Report On Embryonic Stem Cell Research

SR Pharma Taking Stock After Acquiring Rodaris, Joint Venture

EBML Targets Young Companies In Europe With New EUR25M Fund

Bioline Therapeutics Formed By Israeli Groups With $11M Funding

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for March 9, 2026.

Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

Cas and effect: Merck’s phase III ripples HIF-2α space

BioWorld

Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...

Tanycytes in green capturing tau protein in red.

Brain’s hidden tau-clearing pathway uncovered

BioWorld Science

Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 10, 2026

MSD synthesizes α-synuclein PET agents

BioWorld Science

Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...